Study of Ripertamab in Children With Frequent Relapses or Steroid-Dependent Nephrotic Syndrome

NCT07388810 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

312

Enrollment

OTHER

Sponsor class

Conditions

FRNS/SDNS
Ripertamab

Interventions

DRUG: ripertamab
DRUG: ripertamab

Sponsor

Mao Jianhua

Collaborators

Sinocelltech Ltd.